Clinical Trial Update: Ketamine's Efficiency in the Treatment of Chronic Pain: Kynurenin Pathway [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ketamine for chronic pain conditions (including neuralgia) via the kynurenine pathway; current trial status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuralgia
• Pain

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Redar | Conditions: Neuralgia, Chronic Pain | Phase 3 | Status: UNKNOWN